Literature DB >> 28925042

Clinical comparison of actinic changes preceding squamous cell carcinoma vs. intraepidermal carcinoma in renal transplant recipients.

Z Jiyad1,2, P O'Rourke3, H P Soyer4,5, A C Green1,6.   

Abstract

Intraepidermal carcinoma (IEC) is a type of in situ squamous cell carcinoma (SCC), although progression of IEC is rare. We sought to investigate differences between the actinic skin changes preceding the development of both SCC and IEC. Photographs of 63 skin sites at which either SCC or IEC subsequently developed in 37 renal transplant recipients (RTRs) were examined for features of actinic change. We found that areas of skin with an actinic keratosis (AK) > 1 cm2 in size were four times more likely to develop SCC as opposed to IEC (OR = 4.42; 95% CI 1.25-15.60). Skin sites with ≥ 25% of the area affected by AK were again four times more likely to develop SCC than IEC. These results highlight the scale of visible actinic damage required for development of SCC compared with IEC, emphasizing the importance of treating areas of skin with marked visible actinic change to reduce SCC risk in RTRs.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2017        PMID: 28925042     DOI: 10.1111/ced.13211

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

Review 1.  Clinical Characteristics of Actinic Keratosis Associated with the Risk of Progression to Invasive Squamous Cell Carcinoma: A Systematic Review.

Authors:  Alise Balcere; Laura Konrāde-Jilmaza; Laura Agnese Pauliņa; Ingrīda Čēma; Angelika Krūmiņa
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

2.  Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer.

Authors:  Adele C Green; Mandy Way; Mariella Oster; Elsemieke I Plasmeijer; Zainab Jiyad; Peter O'Rourke; Kyoko Miura; Scott Campbell; Nicole Isbel; Daniel C Chambers; Peter Hopkins; Lisa E Ferguson; Marcia Batista Davis; David C Whiteman; H Peter Soyer; Louise Marquart
Journal:  Arch Dermatol Res       Date:  2020-09-05       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.